AI and Life Science Patents: Strategies for Patenting AI-Driven Innovations and Predicting the Impact of the New EU Artificial Intelligence Act on Patent Strategies in Europe

September 28, 2023 2:45pm

Eileen Brandenburger
Head of IP | Patent Attorney
Exscientia

David Sanker
Partner
Morgan, Lewis & Bockius LLP

  • Assessing the latest ways that AI is being used in drug development
  • Analyzing how patent registries and courts are interpreting the existing law in Europe and the U.S. regarding patenting and protecting AI-driven innovations
  • Understanding how companies are navigating patenting challenges surrounding:
    • Eligibility disputes surrounding unpatentable subject matter
    • Satisfaction of the written description and enablement requirements
    • Issues of inventorship and conception
  • Examining the EU Artificial Intelligence Act which is expected to come into force near the end of 2023
    • What will the implications be on AI patenting?
    • How will provisions of the new Act potentially open up a growing area of infringement litigation in the life sciences space?